Bookmark and Share

Edward M. Pickering
 

Edward M. Pickering M.D.

Academic Title: Assistant Professor
Primary Appointment: Medicine
epickering@medicine.umaryland.edu
Location: 110 S Paca Street 2N-139
Phone: 410-328-8141
Fax: 410-328-0177
 

Personal History:

Dr. Pickering graduated from the University of California at Berkeley with a BA in Molecular and Cellular Biology. After working as a research associate at the University of California at San Francisco, he completed his M.D. at St. George's University School of Medicine in Grenada, West Indies. After graduating with honors, he did his residency the University of Connecticut and stayed for another year as Chief Medical Resident. He completed his fellowship training in Pulmonary and Critical Care Medicine at the University of Maryland. After joining the faculty, he completed an additional year of advanced training in Interventional Pulmonology. Dr. Pickering has a joint appointment the the Baltimore VA as the Director of Interventional Pulmonology.

Research Interests:

Dr. Pickering's research interests include early detection of lung cancer, tool development and enhancement, and ablation of early stage lung cancer.


Clinical Specialty:

Dr. Pickering specializes in interventional pulmonology, thoracic oncology, benign/malignant central airway obstruction, minimally invasive diagnosis and staging of lung cancer, and pleural disease.


Publications:

  1. Nielsen UB,Kirpotin DB, Pickering EM, Hong K, Park JW, Refaat Shalaby M, Shao  Y, Benz CC, Marks JD. Therapeutic efficacy ofanti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellularendocytosis. Biochim Biophys Acta. 2002 Aug 19; 1591(1-3):109-118.
  2. Nielsen UB,Kirpotin DB, Pickering EM, Drummond DC, Marks JD. A novel assay for monitoringinternalization of nanocarrier coupled antibodies. BMC Immunol. 2006 Oct 2;7:24.
  3. Luzina IG,Lockatell V, Lavania S, Pickering EM, Kang PH, Bashkatova YN, Andreev SM,Atamas SP. Natural production and functional effects of alternatively splicedinterleukin-4 protein in asthma. Cytokine. 2012 Apr;58(1):20-6.
  4. Luzina IG,Pickering EM, Kopach P, Kang PH, Lockatell V, Todd NW, Papadimitriou JC, McKenzieAN, Atamas SP. Full-Length IL-33 Promotes Inflammation but not Th2 Response InVivo in an ST2-Independent Fashion. J Immunol. 2012 Jul 1;189(1):403-10.
  5. Shah NG, CowanMJ, Pickering E, Sareh H, Afshar M, Fox D, Marron J, Davis J, Herold K, ShanholtzCB, Hasday JD. Nonpharmacologic approach to minimizing shivering during surfacecooling: a proof of principle study. J Crit Care. 2012 Dec;27(6):746.e1-8.
  6. Kopach P1,Lockatell V, Pickering EM, Haskell RE, Anderson RD, Hasday JD, Todd NW, LuzinaIG, Atamas SP. IFN-γ Directly Controls IL-33 Protein Level through a STAT1-and LMP2-dependent Mechanism.  J BiolChem. 2014 Apr 25;289(17):11829-43
  7. Reed, RM.,Eberlein, M., Netzer, G., Pickering, E., Shanholtz, C., Verceles, AC., McCurdy,MT. Diagnostic value of pleural fluid obtained from a chest tube collectionsystem.  Lung 2015 Feb;193(1):141-6.
  8. Sachdeva A,Pickering EM, Lee HJ. From electrocautery, balloon dilatation,neodymium-doped;yttrium-aluminum-garnet (Nd:YAG) laser to argon plasmacoagulation and cryotherapy. J thorac Dis. 2015 Dec; 7(12): s363-s379.
  9. Sachdeva A,Pickering EM, Reed, RM, Shanholtz CB, Ice cream cone sign: reversibleballooning of the trachea due to tracheostomy tube cuff overinflation. BMJ CaseRep. 2016 May.